A carregar...
Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
Chimeric antigen receptor (CAR) T-cell therapy has already achieved remarkable remissions in some difficult-to-treat patients with B-cell malignancies. Although the clinical experience in chronic lymphocytic leukemia (CLL) patients is limited, the proportion of remissions reached in this disease is...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8197365/ https://ncbi.nlm.nih.gov/pubmed/34073911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22115536 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|